Obesity is associated with low-grade inflammation and metabolic syndrome, which is characterized by alterations in glucose, fatty acids, and amino acid metabolism and leads both to a decrease in insulin sensitivity and a decline in one’s ability to adjust to energy availability [2]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.